Haven Hospice & Palliative Care, Llc 700 East Sunflower Road, Suite 9, Cleveland, MS, 38732 | |
(662) 846-0922 |
News Archive
NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.
A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
› Verified 7 days ago
Name | Haven Hospice & Palliative Care, Llc |
---|---|
Location | 700 East Sunflower Road, Suite 9, Cleveland, Mississippi |
Hospice ID | 251673 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 050 |
News Archive
NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.
A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
› Verified 7 days ago
NPI Number | 1518030337 |
Organization Name | Genesis Hospice Care |
Address | 201 West Sunflower Road Cleveland, Mississippi, 38732 |
Phone Number | (662)846-0922 |
News Archive
NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.
A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
› Verified 7 days ago
NPI Number | 1518067834 |
Organization Name | Genesis Hospice Care |
Address | 201 W Sunflower Rd Cleveland, Mississippi, 38732 |
Phone Number | (662)846-0922 |
News Archive
NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.
A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
› Verified 7 days ago
NPI Number | 1578883401 |
Organization Name | Haven Hospice & Palliative Care, Llc |
Address | 700 East Sunflower Road Cleveland, Mississippi, 38732 |
Phone Number | (662)822-5844 |
News Archive
NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.
A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.
A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
› Verified 7 days ago
Home Health Aides | 1 |
Counselors | 1 |
Homemakers | 3 |
Licensed Practical or Vocational Nurses | 2 |
Medical Social Workers | 1 |
Registered Nurses | 2 |
Other Personnel | 5 |
Total Employees | 15 |
---|
News Archive
NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.
A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
› Verified 7 days ago
Others | 3 |
Total Volunteers | 3 |
---|
News Archive
NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.
A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
› Verified 7 days ago
Continue Care Home Health Hospice I I Location: 803 East Sunflower Road, Cleveland, Mississippi, 38732 Phone: (662) 846-0922 |
Grace Community Hospice Location: 808 East Sunflower Road, Cleveland, Mississippi, 38732 Phone: (662) 846-0922 |
Delta Soul Medical, Llc Location: 103 S Court St, Suite 107/mail Po Box 718, Cleveland, Mississippi, 38732 Phone: (662) 846-0922 |
Haven Hospice & Palliative Care, Llc Location: 700 East Sunflower Road, Suite 9, Cleveland, Mississippi, 38732 Phone: (662) 846-0922 |